Cargando…
Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data
Detecting the presence of prostate cancer (PCa) and distinguishing low- or intermediate-risk disease from high-risk disease early, and without the need for potentially unnecessary invasive biopsies remains a significant clinical challenge. The aim of this study is to determine whether the T and B ce...
Autores principales: | Cosma, Georgina, McArdle, Stéphanie E., Foulds, Gemma A., Hood, Simon P., Reeder, Stephen, Johnson, Catherine, Khan, Masood A., Pockley, A. Graham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716718/ https://www.ncbi.nlm.nih.gov/pubmed/34975879 http://dx.doi.org/10.3389/fimmu.2021.786828 |
Ejemplares similares
-
Identifying the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml(−1) Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data
por: Cosma, Georgina, et al.
Publicado: (2017) -
Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data
por: Hood, Simon P, et al.
Publicado: (2020) -
Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation
por: Hood, Simon P., et al.
Publicado: (2019) -
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer
por: Foulds, Gemma A., et al.
Publicado: (2018) -
Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
por: Shackleton, Erin G., et al.
Publicado: (2021)